(1 reference)-
- Target See all IgM products
- IgM
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- FITC
-
Application
- Flow Cytometry (FACS)
- Characteristics
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
- Clone
- M15-8
- Isotype
- IgG1
-
Mouse anti-Human IgM antibody (FITC)
FACS Monoclonal CH2 IgG1 FITC
Mouse anti-Human IgM antibody (APC)FACS Monoclonal CH2 IgG1 APC
Goat anti-Human IgM antibody (Biotin)ELISA, FACS Polyclonal IgG Biotin F(ab')2 fragment
Mouse anti-Human IgM antibody (PE)FACS Monoclonal CH2 IgG1 PE
Goat anti-Human IgM antibody (FITC)ELISA, FACS Polyclonal IgG FITC F(ab')2 fragment
Goat anti-Human IgM (Heavy Chain) antibody (TRITC)ELISA, FACS, IHC Polyclonal IgG TRITC
Goat anti-Human IgM (Heavy Chain) antibody (FITC)ELISA, FACS, IHC Polyclonal IgG FITC
Goat anti-Human IgM (Heavy Chain) antibody (Texas Red (TR))ELISA, FACS, IHC Polyclonal IgG Texas Red (TR)
Goat anti-Human IgM antibody (HRP)ELISA, FACS, FLISA Polyclonal IgG HRP F(ab')2 fragment
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.1 mg/mL
-
-
: "Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte ..." in: International journal of hematology, Vol. 91, Issue 3, pp. 501-8, (2010) (PubMed).
-
: "Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte ..." in: International journal of hematology, Vol. 91, Issue 3, pp. 501-8, (2010) (PubMed).
-
- Target
- IgM
- Abstract
- IgM Products
- Target Type
- Antibody
- Gene ID
- 3507
- UniProt
- P01871
-
You are here:
